DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn
HOMESERVICESABOUT DNA BRIDGES, INC.CLIENTSNEWSROOMCONTACT US

We understand toay's complex markets.

DNA BRIDGES NEWS

2014

January 13-16, 2014
JP MORGAN HEALTHCARE CONFERENCE
San Francisco, CA

February 3, 2014
RRD INTERNATIONAL AND DIPEXIUM PHARMACEUTICALS, LLC PARTNER TO ADVANCE LOCILEX™ THROUGH CLINICAL TRIALS

May 30-June 3, 2014
ASCO 50th Annual Meeting Science & Society
Chicago, IL
More Information >

June 23-26, 2014
BIO INTERNATIONAL CONVENTION
San Diego, CA
More Information >

June 24, 2014
Cook Pharmica, LLC and Selexis SA Establish Customized Biologic Drug Development and Manufacturing Services Platform

June 30, 2014
to-BBB Announces Successful EUR 10 Million Financing

July 7, 2014
Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement With Daiichi Sankyo for Phase 3 Studies of Factor Xa Inhibitor Antidote, Andexanet Alfa, and Edoxaban

September 26-October 1, 2014
ESMO ANNUAL MEETING
Madrid, Spain
More Information >

October 7-9, 2014
CPhI Worldwide Networking Event
Paris Nord Villepinte, France
More Information >

October 26-29, 2014
DNA BRIDGES (DR. GREG LANDES) is PRESENTING at the World ADC conference
San Diego, CA

November 3-5, 2014
BIOEUROPE
Frankfurt, Germany

November 11-12, 2014
WORLD BIOSIMILAR CONFERENCE
Geneva, Switzerland

2013

January 7-10, 2013
JP MORGAN HEALTHCARE CONFERENCE
SAN FRANCISCO, CA

February 29 - March 2, 2013
DNA IS PRESENTING A WORKSHOP ON BIOSIMILAR ANTIBODIES
VISP, SWITZERLAND

March 11-13, 2013
BIOEUROPE SPRING
BARCELONA SPAIN

March 11, 2013
Target Health and LifeOnKey Receive BIRD Foundation Award to Integrate the EMR with the EDC Clinical Trial Database

March 14-16, 2013
ST GALLEN BREAST CANCER CONFERENCE

April 22-25, 2013
BIO INTERNATIONAL CONVENTION
CHICAGO, IL

May 21-23, 2013
DNA IS PRESENTING AT BIOEQUITY
STOCKHOLM SWEDEN

May 31 - June 4, 2013
ASCO ANNUAL MEETING
CHICAGO, IL

July 21, 2013
TechnoSTAT Ltd (Israel) and Target HealthInc. (USA)Partner in EDC and the Paperless Clinical Trial

September 24-26, 2013
DNA is presenting “The ABC for ADDCC and CDC at 4TH ANNUAL BIOSPECIFIC ANTIBODY SUMMIT
BOSTON, MA.

September 26 - October 1, 2013
ESMO ANNUAL MEETING, AMSTERDAM, THE NETHERLANDS

October 14-17, 2013
WORLD ADC CONFERENCE, SAN FRANCISCO, CA
       DNA will conduct a workshop on Biological Factors Critical to ADC Drug Discovery and
       Development -

October 22-24, 2013
WORLD CPHI
FRANKFURT, GERMANY

November 4-6, 2013
BIOEUROPE
VIENNA, AUSTRIA

November 19, 2013
to-BBB Awarded European FP7 Funding in Large Consortium Targeting Epilepsy and Epiletogenesis

November 25, 2013
Portola Pharmaceuticals Receives Breakthrough Therapy Designation From FDA for Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Antidote

December 3, 2013
JHL Biotech, Inc. and Selexis SA Form Biologic Drug Development Alliance to Serve the Biopharmaceutical Industry

2012

January 7-10 , 2012
JP MORGAN HEALTHCARE CONFERENCE
SAN FRANCISCO, CA

April 17, 2012
to-BBB receives Michael J Fox Foundation funding for Parkinson’s disease research

June 1-5, 2012
ASCO ANNUAL MEETING
CHICAGO, IL

June 6. 2012
Irvine Scientific Launches BalanCD™ CHO SLX A Culture Media Developed for the Selexis SURE CHO-M Cell Line

June 15, 2012
Portola Advances PRT4445, Factor Xa Inhibitor Antidote, into Clinical Development

June 18-21, 2012
BIO INTERNATIONAL CONVENTION
BOSTON, MA

June 19-20, 2012
WELLS FARGO SECURTIES RESEARCH & ECONOMICS 2012 HEALTHCARE CONFERENCE
BOSTON, MA

June 21, 2012
BIODALLAS-FORT WORTH BREAKFAST
DALLAS-FORT WORTH, TX
       DNA will present “Evolution of Ehrlich’s Magic Bullets: Today’s Antibody Drugs, Less Magic,
       More Bullet”

July 11, 2012
9th BAYBIO ANNUAL INVESTOR AND ENTREPRENEUR ROUNDTABLE
PALO ALTO, CA

July 24-26, 2012
6th ANTIBODY ENGINEERING & DISCOVERY CONFERENCE
BOSTON, MA
     DNA is leading a preconference workshop on Protein Engineering Approaches to Improve
     Antibody Drug Conjugates and then will be giving opening remarks and chairing the first day’s
     session.

September 6, 2012
MINSTRY OF HEALTH
CAIRO, EGYPT
     DNA will conduct a workshop on assessing biosimilarity requirements of both the WHO and
     EMA.

September 28 – October 2, 2012
ESMO ANNUAL MEETING
VIENNA, AUSTRIA

October 9-12, 2012
WORLD CPHI
MADRID, SPAIN

October 23, 2012
Azaya Therapeutics Initiates BE Study for Regulatory Approval of ATI-0981

November 14, 2012
WOMEN’S ENTREPRENEURSHIP, UN CONFERENCE ON TRADE AND DEVELOPMENT
GENEVA, SWITZERLAND
     DNA will present during the Women’s Entrepreneurship session.

December 13-14, 2012
LIFE SCIENCES SUMMIT
NEW YORK, NEW YORK
     DNA will present on novel translational models between industry and academia.

2011

January 10-13, 2011
JP MORGAN HEALTHCARE CONFERENCE
SAN FRANCISCO, CA

January 24, 2011
RRD Selected as Development Partner for NIH Therapeutics for Rare and Neglected Diseases Program

February 3, 2011
to-BBB realizes EUR 4 million investment round

June 3-6, 2011
ASCO ANNUAL MEETING
CHICAGO, IL

June 20, 2011
Rice Alliance Announces Most Promising Life Sciences Companies at 2011 Life Science Technology Venture Forum

June 27-30, 2011
BIO INTERNATIONAL CONVENTION
WASHINTON, DC

July 26, 2011
CSL Limited Signs Commercial License Agreement with Selexis SA

September 27, 2011
Selexis SA Forms Scientific Advisory Board Headed by Sir Gregory Winter

October 25-27, 2011
WORLD CPHI
FRANKFURT, GERMANY

November 21, 2011
Portola Pharmaceuticals Announces Completion of $89 Million Financing

Decmber 6-10, 2011
SAN ANTONIO BREAST CANCER CONFERENCE
SAN ANTONIO, TEXAS

INDUSTRY AND CLIENT NEWS

 



Newsroom

DNA Bridges Articles

Calendar of Events

Archives
  2014  |  2013  |  2012
  2011  |  2010  |  2009  |  2008
  2007  |  2006  |  2005  |  2004
  2003  |  2002  |  2001  |  2000